GlassScriptPhysician profile
Jonathan Rowland Smith
NPI 1811402951
$968.33
in general payments reported to CMS, 2019-2025
26 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.36 · 2022: $166 · 2023: $198 · 2024: $183 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $130.83 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Insulet Corporation | $86.22 | 2024-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $60.78 | 2021-2023 | |
| Abbvie INC. | $57.23 | 2022-2023 | |
| Verona Pharma, INC. | $54.61 | 2025 | Ohtuvayre |
| Novo Nordisk INC | $51.49 | 2022-2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $51.11 | 2022-2023 | |
| Smith+Nephew, INC. | $46.80 | 2025 | Pico |
| Viatris Specialty LLC | $42.70 | 2025 | Yupelri |
| Dexcom, INC. | $39.47 | 2023 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $38.47 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $35.48 | 2024-2025 | Airsupra, Farxiga |
| Regeneron Healthcare Solutions, INC. | $34.77 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $30.45 | 2025 | Tyvaso |
| Baxter Healthcare | $25.10 | 2024 | Hillrom - Life 2000 Ventilation System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $19.77 | 2024 | |
| Siemens Medical Solutions USA, INC. | $18.24 | 2024 | Dca Systems Hemoglobin A1c Reagent Kit, Clinitek Advantus Analyzer |
| Mylan Specialty L.P. | $17.81 | 2022 | |
| Tactile Systems Technology INC | $17.68 | 2025 | Nimbl, Flexitouch Plus |
| Ani Pharmaceuticals, INC. | $17.51 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $17.27 | 2025 | Durolane |
| Corcept Therapeutics | $16.76 | 2024 | Korlym |
| Heron Therapeutics, INC. | $15.76 | 2023 | Aponvie |
| Lilly USA, LLC | $14.65 | 2021 | |
| Exact Sciences Corporation | $14.27 | 2025 | Cologuard Collection Kit |
| Ambu INC. | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.